Companies /Healthcare

10x Genomics Inc - Class A

NASDAQ: TXG Medical Devices
$76.10
▼ $4.56 (−5.65%) today
Markets closed · 11:15pm ET

24/7 Wall St. View

TXG at a Glance

Valuation
Market cap
$10.5B
Profitability
Revenue (TTM)
$616.9M
Profit margin
-12.2%
EPS (TTM)
$-0.49
Price
52-week range
$11 – $103
24/7 target
$68.65
Street target
$62.13
Earnings
Next report
Nov 5, 2026

Headquartered in Pleasanton, CA Fiscal year ends December NASDAQ: TXG 10xgenomics.com

About 10x Genomics

10x Genomics is a life science technology company that develops integrated solutions — instruments, consumables, and software — for single cell and spatial biology research. Its products enable academic and translational researchers and biopharmaceutical companies to analyze biological systems at high resolution and scale, with applications spanning oncology, immunology, neuroscience, and other fields. The company's spatial portfolio includes Visium and Xenium platforms, while its single cell offerings include the Chromium platform and the recently launched Atera system. 10x Genomics also generates revenue from services and patent licensing. The company recently expanded into multiomics through the acquisition of Proteintech Genomics, adding protein detection capabilities, and is pursuing diagnostics applications through collaborations with major medical institutions. Updated

TXG Coverage

7:40pm ET
Investing

Cathie Wood’s Top Biotech Plays for February

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive technology funds posting high double-digit percentage returns. Notably, the flagship…

Joey Frenette

Frequently Asked Questions

What does 10x Genomics do?

10x Genomics is a life science technology company that develops integrated solutions — instruments, consumables, and software — for single cell and spatial biology research.

What is the TXG stock price target?

24/7 Wall St.'s 12-month price target for TXG is $68.65, rated Hold. The Wall Street consensus target is $62.13. TXG price prediction →